Rapid suppression of spontaneous ventricular arrhythmias during oral amiodarone loading

Soo G. Kim, Michael M. Mannino, Robert Chou, Scott Roth, James A. Roth, Basavaraj Desai, Kevin J. Ferrick, John Devens Fisher

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: To determine the time course of effects of amiodarone during an oral loading period. Design: A prospective, nonrandomized study. Setting: Arrhythmia referral center at a university hospital. Patients: Fifty patients with refractory sustained ventricular tachycardia (n = 44) or ventricular fibrillation (n = 6) and frequent (≥ 30/h) ventricular premature complexes. Intervention: Oral amiodarone, 1200 mg/d for 14 days and 400 mg/d thereafter. Measurements: Ambulatory electrocardiographic monitorings, 12-lead electrocardiograms, and amiodarone blood levels on days 3, 5, 7, 9, 11, 13, and 28. Results: Dramatic reductions of ventricular arrhythmias were noted during the first 72 hours of the therapy. Average ventricular premature complexes/h, couplets/h, and nonsustained ventricular tachycardias/24 h were 524 ± 1224/h, 16 ± 61/h, and 167 ± 611/24 h, respectively, at baseline, and reduced to 140 ± 243/h, 11 ± 50/h, and 33 ± 117/24 h, respectively, on day 3 (P < 0.05 for all). Subsequent reductions of ventricular arrhythmias from day 3 to day 13 were more gradual but were still significant (P < 0.05). A significant reduction of ventricular arrhythmias (≥ 70% reduction of ventricular premature complexes and ≥ 90% reduction of nonsustained ventricular tachycardias) was noted in 50% of patients on day 3, in 65% on day 7, and in 83% on day 13. Prolongation of the QT interval exhibited a similar time course. There were no further differences in reduction of ventricular premature complexes or QT intervals between day 13 and day 28. Conclusions: Oral amiodarone given in loading doses produces rapid and dramatic reductions in spontaneous ventricular arrhythmias within 72 hours. Subsequent reductions of spontaneous arrhythmia were gradual and less dramatic.

Original languageEnglish (US)
Pages (from-to)197-201
Number of pages5
JournalAnnals of Internal Medicine
Volume117
Issue number3
StatePublished - Aug 1 1992

Fingerprint

Amiodarone
Cardiac Arrhythmias
Ventricular Premature Complexes
Ventricular Tachycardia
Ambulatory Electrocardiography
Ventricular Fibrillation
Electrocardiography
Referral and Consultation
Prospective Studies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rapid suppression of spontaneous ventricular arrhythmias during oral amiodarone loading. / Kim, Soo G.; Mannino, Michael M.; Chou, Robert; Roth, Scott; Roth, James A.; Desai, Basavaraj; Ferrick, Kevin J.; Fisher, John Devens.

In: Annals of Internal Medicine, Vol. 117, No. 3, 01.08.1992, p. 197-201.

Research output: Contribution to journalArticle

Kim SG, Mannino MM, Chou R, Roth S, Roth JA, Desai B et al. Rapid suppression of spontaneous ventricular arrhythmias during oral amiodarone loading. Annals of Internal Medicine. 1992 Aug 1;117(3):197-201.
Kim, Soo G. ; Mannino, Michael M. ; Chou, Robert ; Roth, Scott ; Roth, James A. ; Desai, Basavaraj ; Ferrick, Kevin J. ; Fisher, John Devens. / Rapid suppression of spontaneous ventricular arrhythmias during oral amiodarone loading. In: Annals of Internal Medicine. 1992 ; Vol. 117, No. 3. pp. 197-201.
@article{07a13e9df9034ca3a4134a108f1b52c4,
title = "Rapid suppression of spontaneous ventricular arrhythmias during oral amiodarone loading",
abstract = "Objective: To determine the time course of effects of amiodarone during an oral loading period. Design: A prospective, nonrandomized study. Setting: Arrhythmia referral center at a university hospital. Patients: Fifty patients with refractory sustained ventricular tachycardia (n = 44) or ventricular fibrillation (n = 6) and frequent (≥ 30/h) ventricular premature complexes. Intervention: Oral amiodarone, 1200 mg/d for 14 days and 400 mg/d thereafter. Measurements: Ambulatory electrocardiographic monitorings, 12-lead electrocardiograms, and amiodarone blood levels on days 3, 5, 7, 9, 11, 13, and 28. Results: Dramatic reductions of ventricular arrhythmias were noted during the first 72 hours of the therapy. Average ventricular premature complexes/h, couplets/h, and nonsustained ventricular tachycardias/24 h were 524 ± 1224/h, 16 ± 61/h, and 167 ± 611/24 h, respectively, at baseline, and reduced to 140 ± 243/h, 11 ± 50/h, and 33 ± 117/24 h, respectively, on day 3 (P < 0.05 for all). Subsequent reductions of ventricular arrhythmias from day 3 to day 13 were more gradual but were still significant (P < 0.05). A significant reduction of ventricular arrhythmias (≥ 70{\%} reduction of ventricular premature complexes and ≥ 90{\%} reduction of nonsustained ventricular tachycardias) was noted in 50{\%} of patients on day 3, in 65{\%} on day 7, and in 83{\%} on day 13. Prolongation of the QT interval exhibited a similar time course. There were no further differences in reduction of ventricular premature complexes or QT intervals between day 13 and day 28. Conclusions: Oral amiodarone given in loading doses produces rapid and dramatic reductions in spontaneous ventricular arrhythmias within 72 hours. Subsequent reductions of spontaneous arrhythmia were gradual and less dramatic.",
author = "Kim, {Soo G.} and Mannino, {Michael M.} and Robert Chou and Scott Roth and Roth, {James A.} and Basavaraj Desai and Ferrick, {Kevin J.} and Fisher, {John Devens}",
year = "1992",
month = "8",
day = "1",
language = "English (US)",
volume = "117",
pages = "197--201",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "3",

}

TY - JOUR

T1 - Rapid suppression of spontaneous ventricular arrhythmias during oral amiodarone loading

AU - Kim, Soo G.

AU - Mannino, Michael M.

AU - Chou, Robert

AU - Roth, Scott

AU - Roth, James A.

AU - Desai, Basavaraj

AU - Ferrick, Kevin J.

AU - Fisher, John Devens

PY - 1992/8/1

Y1 - 1992/8/1

N2 - Objective: To determine the time course of effects of amiodarone during an oral loading period. Design: A prospective, nonrandomized study. Setting: Arrhythmia referral center at a university hospital. Patients: Fifty patients with refractory sustained ventricular tachycardia (n = 44) or ventricular fibrillation (n = 6) and frequent (≥ 30/h) ventricular premature complexes. Intervention: Oral amiodarone, 1200 mg/d for 14 days and 400 mg/d thereafter. Measurements: Ambulatory electrocardiographic monitorings, 12-lead electrocardiograms, and amiodarone blood levels on days 3, 5, 7, 9, 11, 13, and 28. Results: Dramatic reductions of ventricular arrhythmias were noted during the first 72 hours of the therapy. Average ventricular premature complexes/h, couplets/h, and nonsustained ventricular tachycardias/24 h were 524 ± 1224/h, 16 ± 61/h, and 167 ± 611/24 h, respectively, at baseline, and reduced to 140 ± 243/h, 11 ± 50/h, and 33 ± 117/24 h, respectively, on day 3 (P < 0.05 for all). Subsequent reductions of ventricular arrhythmias from day 3 to day 13 were more gradual but were still significant (P < 0.05). A significant reduction of ventricular arrhythmias (≥ 70% reduction of ventricular premature complexes and ≥ 90% reduction of nonsustained ventricular tachycardias) was noted in 50% of patients on day 3, in 65% on day 7, and in 83% on day 13. Prolongation of the QT interval exhibited a similar time course. There were no further differences in reduction of ventricular premature complexes or QT intervals between day 13 and day 28. Conclusions: Oral amiodarone given in loading doses produces rapid and dramatic reductions in spontaneous ventricular arrhythmias within 72 hours. Subsequent reductions of spontaneous arrhythmia were gradual and less dramatic.

AB - Objective: To determine the time course of effects of amiodarone during an oral loading period. Design: A prospective, nonrandomized study. Setting: Arrhythmia referral center at a university hospital. Patients: Fifty patients with refractory sustained ventricular tachycardia (n = 44) or ventricular fibrillation (n = 6) and frequent (≥ 30/h) ventricular premature complexes. Intervention: Oral amiodarone, 1200 mg/d for 14 days and 400 mg/d thereafter. Measurements: Ambulatory electrocardiographic monitorings, 12-lead electrocardiograms, and amiodarone blood levels on days 3, 5, 7, 9, 11, 13, and 28. Results: Dramatic reductions of ventricular arrhythmias were noted during the first 72 hours of the therapy. Average ventricular premature complexes/h, couplets/h, and nonsustained ventricular tachycardias/24 h were 524 ± 1224/h, 16 ± 61/h, and 167 ± 611/24 h, respectively, at baseline, and reduced to 140 ± 243/h, 11 ± 50/h, and 33 ± 117/24 h, respectively, on day 3 (P < 0.05 for all). Subsequent reductions of ventricular arrhythmias from day 3 to day 13 were more gradual but were still significant (P < 0.05). A significant reduction of ventricular arrhythmias (≥ 70% reduction of ventricular premature complexes and ≥ 90% reduction of nonsustained ventricular tachycardias) was noted in 50% of patients on day 3, in 65% on day 7, and in 83% on day 13. Prolongation of the QT interval exhibited a similar time course. There were no further differences in reduction of ventricular premature complexes or QT intervals between day 13 and day 28. Conclusions: Oral amiodarone given in loading doses produces rapid and dramatic reductions in spontaneous ventricular arrhythmias within 72 hours. Subsequent reductions of spontaneous arrhythmia were gradual and less dramatic.

UR - http://www.scopus.com/inward/record.url?scp=0026708464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026708464&partnerID=8YFLogxK

M3 - Article

VL - 117

SP - 197

EP - 201

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 3

ER -